HEADER ANTIMICROBIAL 06-JAN-06 2CBM TITLE CRYSTAL STRUCTURE OF THE APO-FORM OF A NEOCARZINOSTATIN MUTANT EVOLVED TITLE 2 TO BIND TESTOSTERONE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEOCARZINOSTATIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 35-146; COMPND 5 SYNONYM: NCS, MITOMALCIN, MMC; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CARZINOSTATICUS; SOURCE 3 ORGANISM_TAXID: 1897; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BLR(DE3) PLYSS KEYWDS ANTIBIOTIC, ANTIMICROBIAL, DNA-BINDING, PHAGE-DISPLAY EXPDTA X-RAY DIFFRACTION AUTHOR A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK,F.PECORARI,M.DESMADRIL, AUTHOR 2 H.VAN TILBEURGH,P.MINARD REVDAT 4 13-DEC-23 2CBM 1 REMARK REVDAT 3 24-FEB-09 2CBM 1 VERSN REVDAT 2 26-APR-06 2CBM 1 JRNL REVDAT 1 22-MAR-06 2CBM 0 JRNL AUTH A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK,F.PECORARI, JRNL AUTH 2 M.DESMADRIL,H.VAN TILBEURGH,P.MINARD JRNL TITL STRUCTURES OF IN VITRO EVOLVED BINDING SITES ON JRNL TITL 2 NEOCARZINOSTATIN SCAFFOLD REVEAL UNANTICIPATED EVOLUTIONARY JRNL TITL 3 PATHWAYS. JRNL REF J.MOL.BIOL. V. 358 455 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16529771 JRNL DOI 10.1016/J.JMB.2006.02.002 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.HEYD,F.PECORARI,B.COLLINET,E.ADJADJ,M.DESMADRIL,P.MINARD REMARK 1 TITL IN VITRO EVOLUTION OF THE BINDING SPECIFICITY OF REMARK 1 TITL 2 NEOCARZINOSTATIN, AN ENEDIYNE-BINDING CHROMOPROTEIN. REMARK 1 REF BIOCHEMISTRY V. 42 5674 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12741824 REMARK 1 DOI 10.1021/BI0273664 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 6983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 383 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 790 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.13000 REMARK 3 B22 (A**2) : 0.13000 REMARK 3 B33 (A**2) : -0.25900 REMARK 3 B12 (A**2) : -1.52100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.223 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 45.19 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : MES.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CBM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1290027081. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7137 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 9.380 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1NCO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8 M (NH4)2SO4; 0.1 M MES PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.66933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 32.33467 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.50200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 16.16733 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 80.83667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 64.66933 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 32.33467 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 16.16733 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 48.50200 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 80.83667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2029 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 HAS ANTIBIOTIC ACTIVITY FOR GRAM-POSITIVE BACTERIA REMARK 400 AND ANTITUMOR ACTIVITY FOR CERTAIN MOUSE TUMORS. REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLY 69 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 71 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TRP 73 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 79 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 81 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 86 TO ASN REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A1113 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J5H RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF APO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 1J5I RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A NOVEL CHROMOPROTEIN DERIVED FROMAPO- REMARK 900 NEOCARZINOSTATIN AND A SYNTHETIC CHROMOPHORE REMARK 900 RELATED ID: 1NCO RELATED DB: PDB REMARK 900 HOLO-NEOCARZINOSTATIN (CONTAINING CHROMOPHORE) COMPLEX WITH APO- REMARK 900 CARZINOSTATIN (CONTAINING MPD) REMARK 900 RELATED ID: 1NOA RELATED DB: PDB REMARK 900 NEOCARZINOSTATIN REMARK 900 RELATED ID: 1O5P RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HOLO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 1KVH RELATED DB: PDB REMARK 900 NCSI-GB-BULGE-DNA COMPLEX INDUCED FORMATION OF A DNA BULGESTRUCTURE REMARK 900 BY A MOLECULAR WEDGE LIGAND-POST-ACTIVATEDNEOCARZINOSTATIN REMARK 900 CHROMOPHORE REMARK 900 RELATED ID: 1MP7 RELATED DB: PDB REMARK 900 A THIRD COMPLEX OF POST-ACTIVATED NEOCARZINOSTATINCHROMOPHORE WITH REMARK 900 DNA. BULGE DNA BINDING FROM THE MINORGROOVE REMARK 900 RELATED ID: 2CBO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 3TES24 MUTANT BOUND TO REMARK 900 TESTOSTERONE HEMISUCCINATE. REMARK 900 RELATED ID: 2CBQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 1TES15 MUTANT BOUND TO REMARK 900 TESTOSTERONE HEMISUCCINATE. REMARK 900 RELATED ID: 2CBT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 4TES1 MUTANT BOUND REMARK 900 TESTOSTERONE HEMISUCCINATE. REMARK 999 REMARK 999 SEQUENCE REMARK 999 D33W,G35A,C37W,W39R,L45W,C47Y,F52N DBREF 2CBM A 1 112 UNP P0A3R9 NCZS_STRCZ 35 146 SEQADV 2CBM TRP A 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBM ALA A 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBM TRP A 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBM ARG A 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBM TRP A 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBM TYR A 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBM ASN A 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQRES 1 A 112 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 A 112 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 A 112 GLN ALA GLY THR ALA TYR TRP VAL ALA GLN TRP ALA ARG SEQRES 4 A 112 VAL ASP THR GLY VAL TRP ALA TYR ASN PRO ALA ASP ASN SEQRES 5 A 112 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 A 112 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 A 112 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 A 112 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 A 112 PRO GLU GLY VAL ALA ILE SER PHE HET MES A1113 12 HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID FORMUL 2 MES C6 H13 N O4 S FORMUL 3 HOH *54(H2 O) SHEET 1 AA 3 THR A 4 THR A 8 0 SHEET 2 AA 3 VAL A 18 ALA A 24 -1 O LYS A 20 N THR A 8 SHEET 3 AA 3 ALA A 63 THR A 68 -1 O ALA A 63 N GLY A 23 SHEET 1 AB 3 VAL A 44 TYR A 47 0 SHEET 2 AB 3 ALA A 31 ASP A 41 -1 O ALA A 38 N ALA A 46 SHEET 3 AB 3 SER A 53 THR A 56 -1 O SER A 53 N VAL A 34 SHEET 1 AC 4 VAL A 44 TYR A 47 0 SHEET 2 AC 4 ALA A 31 ASP A 41 -1 O ALA A 38 N ALA A 46 SHEET 3 AC 4 CYS A 93 SER A 98 -1 O GLN A 94 N TRP A 37 SHEET 4 AC 4 VAL A 108 ALA A 109 -1 O VAL A 108 N VAL A 95 SHEET 1 AD 2 SER A 72 PHE A 76 0 SHEET 2 AD 2 ARG A 82 ASP A 87 -1 N TRP A 83 O GLY A 75 SSBOND 1 CYS A 88 CYS A 93 1555 1555 2.03 CISPEP 1 THR A 8 PRO A 9 0 -0.44 SITE 1 AC1 6 TRP A 37 ARG A 39 GLY A 43 TRP A 45 SITE 2 AC1 6 GLY A 96 GLY A 102 CRYST1 60.125 60.125 97.004 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016632 0.009603 0.000000 0.00000 SCALE2 0.000000 0.019205 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010309 0.00000